Advertisement
Screener

MiMedx Group, Inc. (MDXG) Current Income Tax Expense (Benefit)

MiMedx Group, Inc. Current Income Tax Expense (Benefit)

MiMedx Group, Inc. (MDXG) reported Current Income Tax Expense (Benefit) of $8.97 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.

Financial Statements › Expense Statement › Income Tax

us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-02-25

  • MiMedx Group, Inc. current income tax expense (benefit) for fiscal 2025 was $8.97M, a 217.78% increase from fiscal 2024.
  • MiMedx Group, Inc. current income tax expense (benefit) for fiscal 2024 was $2.82M, a 182.97% increase from fiscal 2023.
  • MiMedx Group, Inc. current income tax expense (benefit) for fiscal 2023 was $998.00K, a 384.47% increase from fiscal 2022.
  • MiMedx Group, Inc. current income tax expense (benefit) for fiscal 2022 was $206.00K, a 16.60% decline from fiscal 2021.
Period endCurrent Income Tax Expense (Benefit) 12 monthCurrent Income Tax Expense (Benefit) 12 month as first filed
2025-12-31$8.97M
10-K · filed 2026-02-25
2024-12-31$2.82M
10-K · filed 2026-02-25
2023-12-31$998.00K
10-K · filed 2026-02-25
2022-12-31$206.00K
10-K · filed 2025-02-26
2021-12-31$247.00K
10-K · filed 2024-02-28
2020-12-31-$12.26M
10-K · filed 2023-02-28
2019-12-31-$5.00K
10-K · filed 2022-02-28
2018-12-31$1.04M
10-K · filed 2021-03-08
2017-12-31$7.03M
10-K · filed 2020-07-06
2016-12-31$5.53M
10-K · filed 2020-03-17
$6.12M
10-K · filed 2017-03-01
2015-12-31$9.67M
10-K · filed 2017-03-01
2014-12-31$832.00K
10-K · filed 2017-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
SpyGlass Pharma, Inc. (SGP)United States$0.925B